Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole + moxifloxacin + amoxicillin rescue therapy duration study for Helicobacter pylori infection
2006-004323-10Phase 3Completed
- Sponsor
- Technische Universität Dresden
- Start
- Jan 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of esomeprazole, moxifloxacin and amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Technische Universität Dresden. Primary endpoints: Helicobacter pylori eradication rate and Endoscopy with culture and antibiogram after treatment failure. Started Jan 2007; status: completed.
02
Drugs
esomeprazolemoxifloxacinamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on 2006-004323-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004323-10.